Drug intelligence / Profile preview

MPS1

Development stage
Unknown
Lead developer
Cancer Research Horizons
Modality
Small Molecules
Administration
Oral
01

Overview

MPS1 is a small molecule inhibitor of the Monopolar Spindle 1 (MPS1) kinase, also known as TTK protein kinase, currently under development by Cancer Research Horizons for the treatment of multiple cancer indications. MPS1 is a dual-specificity kinase that plays a critical role in the spindle assembly checkpoint (SAC), a surveillance mechanism that ensures accurate chromosome segregation during mitosis by preventing the onset of anaphase until all chromosomes are properly attached to the spindle. By inhibiting MPS1, the drug disrupts the SAC, leading to premature mitotic exit, chromosomal instability, aneuploidy, and the induction of apoptosis (cell death) in rapidly dividing cancer cells. The asset is currently in Phase 1 clinical development to evaluate its safety, tolerability, and preliminary anti-tumor activity.

Other names
MPS1 inhibitorMPS-1 inhibitorMPS 1 inhibitorTTK inhibitorMonopolar spindle 1 inhibitor
02

Targets

TTK (TTK protein kinase)

Beyond the preview

Go deeper on MPS1.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MPS1.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call